Framework models of tumor dormancy from patient-derived observations.

[1]  J. Thomas,et al.  Transmission of donor melanoma by organ transplantation. , 2010, The Lancet. Oncology.

[2]  R. M. Simpson,et al.  Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. , 2010, Cancer research.

[3]  G. Haroske,et al.  Late recurrence (10 years or more) of malignant melanoma in south‐east Germany (Saxony) A single‐centre analysis of 1881 patients with a follow‐up of 10 years or more , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  J. Abastado,et al.  Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. , 2010, The Journal of clinical investigation.

[5]  M. Röcken.  Early tumor dissemination, but late metastasis: insights into tumor dormancy. , 2010, The Journal of clinical investigation.

[6]  Päivi Heikkilä,et al.  Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies , 2010, PLoS medicine.

[7]  A. Chambers,et al.  Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. , 2010, European journal of cancer.

[8]  N. Stoecklein,et al.  Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis , 2010, International journal of cancer.

[9]  J. Aguirre-Ghiso,et al.  Dormancy of metastatic melanoma , 2010, Pigment cell & melanoma research.

[10]  K. Pienta,et al.  GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche. , 2010, Neoplasia.

[11]  A. Barabasi,et al.  Cancer metastasis networks and the prediction of progression patterns , 2009, British Journal of Cancer.

[12]  P. Bragado,et al.  Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. , 2009, Cancer research.

[13]  C. Klein,et al.  Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.

[14]  T. Ragg,et al.  Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Iwama,et al.  TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. , 2009, Blood.

[16]  R. Amaravadi.  Autophagy-induced tumor dormancy in ovarian cancer. , 2008, The Journal of clinical investigation.

[17]  Zhen Lu,et al.  The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. , 2008, The Journal of clinical investigation.

[18]  Sabine Riethdorf,et al.  Review: Biological relevance of disseminated tumor cells in cancer patients , 2008, International journal of cancer.

[19]  James M. Roberts,et al.  Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1 , 2008, Science.

[20]  S. Lockett,et al.  Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. , 2008, Cancer research.

[21]  J. Aguirre-Ghiso,et al.  ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo , 2008, Proceedings of the National Academy of Sciences.

[22]  B. Quesnel.  Tumor dormancy and immunoescape   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[23]  L. Akslen,et al.  Tumor‐vascular interactions and tumor dormancy   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[24]  S. Indraccolo,et al.  Cellular interactions in the vascular niche: implications in the regulation of tumor dormancy   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[25]  C. Horak,et al.  The role of metastasis suppressor genes in metastatic dormancy   , 2008 .

[26]  P. Goss,et al.  New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target? , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[27]  M. Schwaiger,et al.  TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. , 2008, Cancer cell.

[28]  Odd O Aalen,et al.  Breast cancer tumor growth estimated through mammography screening data , 2008, Breast Cancer Research.

[29]  A. Ullrich,et al.  Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer. , 2008, Cancer cell.

[30]  J. Aguirre-Ghiso,et al.  Dual function of pancreatic endoplasmic reticulum kinase in tumor cell growth arrest and survival. , 2008, Cancer research.

[31]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[32]  C. Sotiriou,et al.  Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures , 2007, Breast Cancer Research.

[33]  J. Aguirre-Ghiso,et al.  Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.

[34]  J. Chirgwin,et al.  Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases , 2006, Clinical Cancer Research.

[35]  A. Iwama,et al.  Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells , 2006, The EMBO journal.

[36]  James M. Roberts,et al.  A New Description of Cellular Quiescence , 2006, PLoS biology.

[37]  J. Aguirre-Ghiso,et al.  Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. , 2006, Cancer research.

[38]  R. Eils,et al.  Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer. , 2005, Cancer cell.

[39]  E. Woodle,et al.  Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. , 2005, Transplantation proceedings.

[40]  S. Formenti,et al.  Recombinant (cid:2) 2(IV)NC1 Domain Inhibits Tumor Cell-Extracellular Matrix Interactions, Induces Cellular Senescence, and Inhibits Tumor Growth in Vivo , 2005 .

[41]  Tanja Fehm,et al.  Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.

[42]  G. Sethuraman,et al.  Donors with central nervous system malignancies: are they truly safe? , 2003, Transplantation.

[43]  R. Eils,et al.  From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Aguirre-Ghiso,et al.  ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK , 2003 .

[45]  R. MacKie,et al.  Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. , 2003, The New England journal of medicine.

[46]  J. Leman,et al.  Late (> 10 years) recurrence of melanoma: the Scottish experience , 2003, The British journal of dermatology.

[47]  G. Mundy.  Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[48]  H. Rilo,et al.  Transmission of donor cancer into cardiothoracic transplant recipients. , 2001, Surgery.

[49]  C. Klein,et al.  Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. , 2001, Seminars in cancer biology.

[50]  R. Demicheli,et al.  Tumour dormancy: findings and hypotheses from clinical research on breast cancer. , 2001, Seminars in cancer biology.

[51]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[52]  J. Aguirre-Ghiso,et al.  Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. , 2001, Molecular biology of the cell.

[53]  G. A.,et al.  Late metastases of cutaneous melanoma: an analysis of 31 patients. , 2000 .

[54]  K. Weinberg,et al.  Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  G. Everson,et al.  Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. , 2000, Transplantation.

[56]  T. Wilt,et al.  Epidemiology of High-Grade Prostatic Intraepithelial Neoplasia , 2000, Scandinavian journal of urology and nephrology. Supplementum.

[57]  D J Ferguson,et al.  Dormancy of mammary carcinoma after mastectomy. , 1999, Journal of the National Cancer Institute.

[58]  A. Sober,et al.  Ultra‐late recurrence (15 years or longer) of cutaneous melanoma , 1997, Cancer.

[59]  M. Hundeiker,et al.  Melanomerstmetastasen nach 10 und mehr Jahren Erscheinungsfreiheit , 1997, Der Hautarzt.

[60]  D. Grignon,et al.  EPIDEMOLOGY OF HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA , 1995 .

[61]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[62]  W. Friedl,et al.  Langzeitprognose des mammakarzinoms retrospektive untersuchung an 973 patientinnen , 1992, Langenbecks Archiv für Chirurgie.

[63]  H. Joensuu,et al.  Comparison of breast carcinomas diagnosed in the 1980s with those diagnosed in the 1940s to 1960s. , 1991, BMJ.

[64]  H. Seigler,et al.  Late Recurrence of Malignant Melanoma: Analysis of 168 Patients , 1990, Annals of surgery.

[65]  J. A. Andersen,et al.  Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. , 1987, British Journal of Cancer.

[66]  G. Schlimok,et al.  Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[67]  C. Beattie,et al.  Late relapse from cutaneous stage I malignant melanoma. , 1985, Archives of surgery.

[68]  G. Hadfield.  The Dormant Cancer Cell* , 1954, British medical journal.

[69]  R. A. Willis.  The Spread of Tumours in the Human Body , 1934, Nature.

[70]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[71]  C. Melief,et al.  Cancer immunology. , 2011, Current opinion in immunology.

[72]  James M. Roberts,et al.  Hijacking HES1: how tumors co-opt the anti-differentiation strategies of quiescent cells. , 2010, Trends in molecular medicine.

[73]  J. Wisell,et al.  Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures , 2010 .

[74]  A. Chambers,et al.  Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis. , 2006, Breast disease.

[75]  Rosalba Miceli,et al.  Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy , 2005, Breast Cancer Research and Treatment.

[76]  S. Formenti,et al.  Recombinant alpha2(IV)NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo. , 2005, The American journal of pathology.

[77]  R. Alloway,et al.  Donor transmitted malignancies. , 2004, Annals of transplantation.

[78]  J. Aguirre-Ghiso,et al.  ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). , 2003, Cancer research.

[79]  G. Plewig,et al.  Late metastases of cutaneous melanoma: an analysis of 31 patients. , 2000, Journal of the American Academy of Dermatology.

[80]  A. Lippold,et al.  [First melanoma metastases after 10 years and more of remission]. , 1997, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[81]  Lars Holmgren,et al.  Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.

[82]  C. Herfarth,et al.  [The long-term prognosis of breast cancer. Retrospective study of 973 patients]. , 1992, Langenbecks Archiv fur Chirurgie.